BG00012
Drug timelines are a Plus or Pro feature.
13 regulatory and trial events tracked for BG00012, covering 2013-09-16 to 2023-08-28. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of BG00012 in MS [Phase 2]